The yellow fever 17D vaccine virus: Molecular basis of viral attenuation and its use as an expression vector

被引:17
|
作者
Galler, R [1 ]
Freire, MS [1 ]
Jabor, AV [1 ]
Mann, GF [1 ]
机构
[1] FIOCRUZ MS, LAB TECNOL VIROL, INST TECNOL IMUNOBIOL, BR-21045900 RIO DE JANEIRO, BRAZIL
关键词
flavivirus; yellow fever virus; attenuation; vaccine; gene expression;
D O I
10.1590/S0100-879X1997000200002
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The yellow fever (YF) virus is the prototype flavivirus. The use of molecular techniques has unraveled the basic mechanisms of viral genome structure and expression. Recent trends in flavivirus research include the use of infectious clone technology with which it is possible to recover virus from cloned cDNA. Using this technique, mutations can be introduced at any point of the viral genome and their resulting effect on virus phenotype can be assessed. This approach has opened new possibilities to study several biological viral features with special emphasis on the issue of virulence/attenuation of the YF virus. The feasibility of using YF virus 17D vaccine strain, for which infectious cDNA is available, as a vector for the expression of heterologous antigens is reviewed.
引用
收藏
页码:157 / 168
页数:12
相关论文
共 50 条
  • [41] Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone
    Jiang, Xiaohong
    Dalebout, Tim J.
    Lukashevich, Igor S.
    Bredenbeek, Peter J.
    Franco, David
    [J]. JOURNAL OF GENERAL VIROLOGY, 2015, 96 : 804 - 814
  • [42] Yellow fever 17D vaccine virus isolated from healthy vaccinees accumulates very few mutations
    Xie, H
    Cass, AR
    Barrett, ADT
    [J]. VIRUS RESEARCH, 1998, 55 (01) : 93 - 99
  • [43] A first look at the protective immunity elicited by the yellow fever virus 17D live-attenuated vaccine
    Watson, Alan
    Lam, L. K. Metthew
    Gardner, Christina
    Klimstra, William
    Ryman, Kate
    [J]. JOURNAL OF IMMUNOLOGY, 2014, 192
  • [44] Mutation in NS5 protein attenuates mouse neurovirulence of yellow fever 17D vaccine virus
    Xie, H
    Ryman, KD
    Campbell, GA
    Barrett, ADT
    [J]. JOURNAL OF GENERAL VIROLOGY, 1998, 79 : 1895 - 1899
  • [45] 17D YELLOW-FEVER VACCINE VIRUS ENVELOPE PROTEIN EXPRESSED BY RECOMBINANT BACULOVIRUS IS ANTIGENICALLY INDISTINGUISHABLE FROM AUTHENTIC VIRAL PROTEIN
    SHIU, SYW
    MORIKAWA, S
    BUCKLEY, A
    HIGGS, S
    KARUNAKARANNAIR, V
    BLACHERE, C
    GOULD, EA
    [J]. JOURNAL OF GENERAL VIROLOGY, 1991, 72 : 1451 - 1454
  • [46] The yellow fever 17D vaccine and risk of malignant melanoma in the United States military
    Hodges-Vazquez, Meredith
    Wilson, James P.
    Hughes, Hayley
    Garman, Patrick
    [J]. VACCINE, 2012, 30 (30) : 4476 - 4479
  • [47] Mutagenesis of the RGD motif in the yellow fever virus 17D envelope protein
    van der Most, RG
    Corver, J
    Strauss, JH
    [J]. VIROLOGY, 1999, 265 (01) : 83 - 95
  • [48] The duration of immunity following vaccination with the 17D strain of yellow fever virus
    Fox, JP
    Cabral, AS
    [J]. AMERICAN JOURNAL OF HYGIENE, 1943, 37 (01): : 93 - 120
  • [49] The yellow fever 17D virus as a platform for new live attenuated vaccines
    Bonaldo, Myrna C.
    Sequeira, Patricia C.
    Galler, Ricardo
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (05) : 1256 - 1265
  • [50] Deconvoluting protective immune responses elicited by the live-attenuated 17D yellow fever virus vaccine
    Watson, Alan
    Lam, L. K. Metthew
    Klimstra, William
    Ryman, Kate
    [J]. JOURNAL OF IMMUNOLOGY, 2013, 190